SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-20-000004
Filing Date
2020-02-18
Accepted
2020-02-18 16:04:04
Documents
4
Period of Report
2020-02-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20200218x8k.htm 8-K 43173
2 EX-10.1 bpmx-20200218ex1015ca3a4.htm EX-10.1 45353
3 GRAPHIC bpmx20200218ex1015ca3a4001.jpg GRAPHIC 89239
4 GRAPHIC bpmx20200218ex1015ca3a4002.jpg GRAPHIC 89239
  Complete submission text file 0001504167-20-000004.txt   334757
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 20625242
SIC: 2834 Pharmaceutical Preparations